Day: October 22, 2022

A new XLH treatment will soon be available for Australian children and adults. On the eve of International XLH Awareness Day (23 October),  this is the news Australia’s XLH community has been waiting for. From 1 November, CRYSVITA® (burosumab) will be subsidised through the Pharmaceutical Benefits Scheme (PBS)3 for Australian children and adults living with a disease, known as X-linked